Blood marker study to predict severe bacterial lung infection
Part of Heart & circulation, Infections, Lungs & breathing clinical trials.
This study looks at specific immune cells and how fats are transported in the blood to predict which people will have a severe bacterial infection (like pneumonia or sepsis). Your results may help doctors identify higher-risk patients earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a severe bacterial lung infection from the community (pneumonia) and/or sepsis.
- Your infection is considered severe based on common medical scoring (SOFA score above 2).
- You can follow all study instructions and complete required study tests.
- You can give informed consent (or have it provided appropriately).
- You have not had certain key health conditions or medicines that could affect results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain markers in the blood to help predict and understand lung injury in people who have sepsis from an infection outside the lungs. By joining, you help doctors learn how to better protect the lungs of future patients with sepsis.
This study is testing a blood test that may help doctors diagnose sepsis faster. It involves people with sepsis and healthy volunteers to compare results.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
This trial is testing whether certain markers in your blood or other samples can help doctors diagnose sepsis (a severe infection that affects your organs) more quickly. If you join, the study will use samples already collected to look for these markers, which might lead to faster treatment for future patients.
This study looks at blood test “markers” to tell the difference between infection and non-infectious illness. It may help doctors recognize infection earlier and avoid confusion with other conditions.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.